Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multicenter, Multinational Study of Lacosamide as First Add-On Anti-epileptic Drug (AED) Treatment in Subjects With Partial-Onset Seizures

NCT00955357 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00955357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00955357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multicenter, Multinational Study of Lacosamide as First Add-On Anti-epileptic Drug (AED) Treatment in Subjects With Partial-Onset Seizures
Lead sponsor
UCB Pharma
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2009
Completion date
August 31, 2013
Enrollment
461 (actual)
Sites
109

Conditions

As the registry lists them; a condition with its own page is linked.

partial epilepsies